Vicarious Surgical Inc. logo

Vicarious Surgical Inc. (RBOT)

Market Closed
12 Dec, 20:00
NYSE NYSE
$
2. 57
-0.14
-5.17%
$
15.86M Market Cap
- P/E Ratio
0% Div Yield
53,185 Volume
-0.38 Eps
$ 2.71
Previous Close
Day Range
2.57 2.8
Year Range
2.44 18.97
Want to track RBOT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

RBOT closed Friday lower at $2.57, a decrease of 5.17% from Thursday's close, completing a monthly decrease of -4.81% or $0.13. Over the past 12 months, RBOT stock lost -80.89%.
RBOT is not paying dividends to its shareholders.
The last earnings report, released on Nov 13, 2025, exceeded the consensus estimates by 0.42%. On average, the company has surpassed earnings expectations by 1.72%, based on the last three reports.
Vicarious Surgical Inc. has completed 1 stock splits, with the recent split occurring on Jun 13, 2024.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on NYSE (USD).

RBOT Chart

Similar

Nuvation Bio Inc.
$ 0.3
+10.14%
Allurion Technologies Inc.
$ 1.68
+1.2%
CCM
Concord Medical Services Holdings Ltd. - Sponsored ADR
$ 4.29
-3.92%
Vicarious Surgical Inc. (RBOT) Q3 2025 Earnings Call Transcript

Vicarious Surgical Inc. (RBOT) Q3 2025 Earnings Call Transcript

Vicarious Surgical Inc. ( RBOT ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Stephen From - CEO & Director Sarah Romano - CFO & Treasurer Conference Call Participants Marissa Bych - Gilmartin Group LLC Joshua Jennings - TD Cowen, Research Division Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Presentation Operator Good afternoon. Thank you for attending the Vicarious Surgical's 2025 Third Quarter Earnings Call.

Seekingalpha | 1 month ago
Vicarious Surgical Inc. (RBOT) Q2 2025 Earnings Call Transcript

Vicarious Surgical Inc. (RBOT) Q2 2025 Earnings Call Transcript

Vicarious Surgical Inc. (NYSE:RBOT ) Q2 2025 Earnings Conference Call August 12, 2025 4:30 AM ET Company Participants Adam David Sachs - Co-Founder, President & Director Sarah Romano - CFO & Treasurer Stephen From - CEO & Director Conference Call Participants Adam Carl Maeder - Piper Sandler & Co., Research Division Eric Evan Anderson - TD Cowen, Research Division Ryan Benjamin Zimmerman - BTIG, LLC, Research Division Marissa Elizabeth Bych - Gilmartin Group LLC Operator Good afternoon. Thank you for attending the Vicarious Surgical's 2025 Second Quarter Earnings Call.

Seekingalpha | 4 months ago
Vicarious Surgical Inc. (RBOT) Q1 2025 Earnings Call Transcript

Vicarious Surgical Inc. (RBOT) Q1 2025 Earnings Call Transcript

Vicarious Surgical Inc. (NYSE:RBOT ) Q1 2025 Results Conference Call May 12, 2025 4:30 PM ET Company Participants Webb Campbell - Investor Relations Adam Sachs - Co-Founder and CEO Sarah Romano - CFO Conference Call Participants Eric Anderson - TD Cowen Operator Hello everyone, and welcome to the Vicarious Surgical's 2025 First Quarter Earnings Call. My name is Nadia, and I'll be coordinating the call today.

Seekingalpha | 7 months ago

Vicarious Surgical Inc. (RBOT) FAQ

What is the stock price today?

The current price is $2.57.

On which exchange is it traded?

Vicarious Surgical Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is RBOT.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 15.86M.

Has Vicarious Surgical Inc. ever had a stock split?

Vicarious Surgical Inc. had 1 splits and the recent split was on Jun 13, 2024.

Vicarious Surgical Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Stephen From CEO
NYSE Exchange
92561V109 CUSIP
US Country
123 Employees
- Last Dividend
13 Jun 2024 Last Split
4 Sep 2020 IPO Date

Overview

Vicarious Surgical Inc. represents a pioneering force in the healthcare technology sector, specializing in the development and sale of advanced surgical robots within the United States. Founded in 2014 and headquartered in Waltham, Massachusetts, this innovative company has positioned itself at the forefront of minimally invasive surgical solutions. Vicarious Surgical Inc. leverages cutting-edge robotics to enhance the capabilities of surgeons, ultimately aiming to improve patient outcomes and redefine standards within surgical practices.

Products and Services

  • Vicarious Surgical System
  • This flagship product by Vicarious Surgical Inc. stands as a testament to the company's innovative spirit and engineering prowess. The Vicarious Surgical System is a sophisticated single-port surgical robot designed to virtually transport surgeons inside the patient. Through this unique approach, the system allows for precision-guided minimally invasive surgery, significantly reducing recovery times and potential complications associated with traditional surgical methods. The agility and flexibility of the robotic platform enable a range of complex procedures to be performed with enhanced control and visibility, marking a significant leap forward in surgical technology.

Contact Information

Address: 78 Fourth Avenue
Phone: 617 868 1700